PSY27 Cost-Consequence Analysis Comparing Romiplostim to Rituximab in the Treatment of Adult Primary Immune Thrombocytopenia (Itp) in France

Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.999
https://www.valueinhealthjournal.com/article/S1098-3015(11)02561-7/fulltext
Title : PSY27 Cost-Consequence Analysis Comparing Romiplostim to Rituximab in the Treatment of Adult Primary Immune Thrombocytopenia (Itp) in France
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02561-7&doi=10.1016/j.jval.2011.08.999
First page : A415
Section Title : Systemic Disorders/Conditions
Open access? : No
Section Order : 961
Categories :
Tags :
Regions :
ViH Article Tags :